Affidea Expands with Acquisition of Uroviva Group
Deal News | Apr 07, 2025 | Legal Community Swiss
Affidea, an outpatient healthcare provider, has expanded its operations significantly with the acquisition of Uroviva Group, a network of specialists in Switzerland. The acquisition nearly doubles Affidea's size, increasing its centers from 17 to 33 and its staff from 450 to 700. This move also allows Affidea to broaden its services by developing a prostate cancer care pathway, complementing its existing focus on breast cancer care. The transaction was advised by Niederer Kraft Frey (NKF) for Affidea, and Advestra for the German Equity Partners IV and other sellers. NKF's team was led by corporate/M&A partner Philippe Weber and healthcare/regulatory partner Janine Reudt-Demont, while Friedrich Graf von Westphalen Partner provided German law expertise. Advestra's team included several prominent lawyers specializing in corporate M&A and finance. The acquisition enhances Affidea's capabilities in pathology, diagnostic imaging, and oncology.
Sectors
- Healthcare
- Private Equity
- Legal Services
Geography
- Switzerland – The acquisition involves Uroviva Group, which operates in Switzerland with 16 locations.
- Germany – The sellers included German Equity Partners IV, and German law expertise was provided by Friedrich Graf von Westphalen Partner.
Industry
- Healthcare – Affidea and Uroviva are both involved in healthcare services, particularly in diagnostic and treatment pathways for cancer.
- Private Equity – German Equity Partners IV, managed by ECM Equity Capital Management, participated in the transaction as a seller.
- Legal Services – The law firms Niederer Kraft Frey and Advestra provided legal advice for the acquisition, highlighting the importance of legal counsel in M&A activities.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Affidea | Buyer | Company | An outpatient healthcare provider specializing in diagnostic services. |
| Uroviva Group | Target | Company | A network of medical specialists in urology, gynaecology, and oncology in Switzerland. |
| ECM Equity Capital Management | Private Equity Firm | Company | Manages German Equity Partners IV, which was involved as a seller in the transaction. |
| Niederer Kraft Frey (NKF) | Legal Advisor to Buyer | Company | Provided legal advice to Affidea for the acquisition. |
| Advestra | Legal Advisor to Seller | Company | Advised German Equity Partners IV and other sellers on the transaction. |
| Friedrich Graf von Westphalen Partner | Legal Advisor for German Law | Company | Collaborated with NKF on German law matters pertaining to the acquisition. |